The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Nasdaq provides an interactive stock information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have ...

Here's 2 High-Yielding S&P 500 Stocks to Buy in 2025, According to Wall Street. Prediction: This $43 Billion Bet Will Help Pfizer Stock Take Off in 2025.

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

And when a stock's fair value is higher than its current market price, investors tend ... to earnings estimates, Pfizer is rated Zacks Rank #2 (Buy). The chart below shows the evolution of the ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Pfizer is expected to post earnings of $0.49 ...

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...

During this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has gained 0%. The key question now is: What could be the stock's future direction? Although media reports or ...